The Role of Inflammation in Post-TAVI Outcomes.
作者信息
Melo Pedro H M C de, Modolo Rodrigo
机构信息
Departamento de Cardiologia Intervencionista - Hospital Sírio Libanês, São Paulo, SP - Brasil.
Departamento de Clínica Médica - Divisão de Cardiologia - Faculdade de Ciências Médicas - Universidade Estadual de Campinas (UNICAMP), Campinas, SP - Brasil.
出版信息
Arq Bras Cardiol. 2021 Nov;117(5):1028-1029. doi: 10.36660/abc.20210809.
Abstract
摘要
相似文献
1
The Role of Inflammation in Post-TAVI Outcomes.炎症在经导管主动脉瓣植入术后结果中的作用。
Arq Bras Cardiol. 2021 Nov;117(5):1028-1029. doi: 10.36660/abc.20210809.
2
Transcatheter aortic valve replacement acutely improves left ventricular mechanical efficiency in severe aortic stenosis: effects of different phenotypes.经导管主动脉瓣置换术可显著改善重度主动脉瓣狭窄患者的左心室机械效率：不同表型的影响。
Clin Res Cardiol. 2020 Jul;109(7):819-831. doi: 10.1007/s00392-019-01570-3. Epub 2019 Nov 20.
3
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.经导管主动脉瓣植入术治疗严重主动脉瓣狭窄患者的更新临床适应证：意大利心脏病学会和 GISE 的专家意见。
J Cardiovasc Med (Hagerstown). 2018 May;19(5):197-210. doi: 10.2459/JCM.0000000000000636.
4
The expanding indications of transcatheter aortic valve implantation.经导管主动脉瓣植入术的适应证不断扩大。
Future Cardiol. 2016 Mar;12(2):209-19. doi: 10.2217/fca.15.86. Epub 2016 Feb 26.
5
Role of Echocardiography Before Transcatheter Aortic Valve Implantation (TAVI).经导管主动脉瓣植入术（TAVI）前超声心动图的作用。
Curr Cardiol Rep. 2016 Apr;18(4):38. doi: 10.1007/s11886-016-0715-z.
6
Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study.经导管主动脉瓣植入术（TAVI）与主动脉瓣置换术（SAVR）治疗主动脉瓣狭窄的成本比较研究。
Heart Lung Circ. 2021 Dec;30(12):1918-1928. doi: 10.1016/j.hlc.2021.05.088. Epub 2021 Jul 2.
7
Reduced inflammatory response by transcatheter, as compared to surgical aortic valve replacement.与外科主动脉瓣置换术相比，经导管介入可降低炎症反应。
Scand Cardiovasc J. 2018 Feb;52(1):43-50. doi: 10.1080/14017431.2017.1416157. Epub 2017 Dec 12.
8
Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement.经导管主动脉瓣植入术与外科主动脉瓣置换术后感染性心内膜炎的发生率和结局。
Clin Microbiol Infect. 2020 Oct;26(10):1368-1374. doi: 10.1016/j.cmi.2020.01.036. Epub 2020 Feb 6.
9
Transcatheter Aortic Valve Replacement in Low-Risk Patients Within the Observational Study of Effectiveness of SAVR-TAVI Procedures for Severe Aortic Stenosis Treatment Study: Observing the Unobserved.在严重主动脉瓣狭窄治疗的外科主动脉瓣置换术-经导管主动脉瓣置换术（SAVR-TAVI）程序有效性观察研究中低风险患者的经导管主动脉瓣置换术：观察未观察到的情况。
Circ Cardiovasc Interv. 2016 May;9(5):e003830. doi: 10.1161/CIRCINTERVENTIONS.116.003830.
10
[Is transcatheter aortic valve implantation superior to surgical valve replacement?].经导管主动脉瓣植入术是否优于外科瓣膜置换术？
Ned Tijdschr Geneeskd. 2016;160:D905.
引用本文的文献
1
The Prognostic Significance of Uric Acid/Albumin Ratio in Patients with Aortic Stenosis Following Transcatheter Aortic Valve Implantation for Major Adverse Cardiac and Cerebral Events.经导管主动脉瓣置换术治疗主动脉瓣狭窄患者血尿酸/白蛋白比值与主要心脑不良事件的预后意义。
Medicina (Kaunas). 2023 Mar 30;59(4):686. doi: 10.3390/medicina59040686.
2
Transcatheter Aortic Valve Implant in Latin America - We will Get There!拉丁美洲的经导管主动脉瓣植入术——我们终将实现！
Arq Bras Cardiol. 2022 Jun 10;118(6):1097-1098. doi: 10.36660/abc.20220325.
本文引用的文献
1
C-reactive Protein as a Prognostic Marker of 1-Year Mortality after Transcatheter Aortic Valve Implantation in Aortic Stenosis.C-反应蛋白作为主动脉瓣狭窄经导管主动脉瓣植入术后 1 年死亡率的预后标志物。
Arq Bras Cardiol. 2021 Nov;117(5):1018-1027. doi: 10.36660/abc.20190715.
2
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术的STS-ACC TVT注册研究
J Am Coll Cardiol. 2020 Nov 24;76(21):2492-2516. doi: 10.1016/j.jacc.2020.09.595.
3
Additive Value of High-Density Lipoprotein Cholesterol and C-Reactive Protein Level Assessment for Prediction of 2-year Mortality After Transcatheter Aortic Valve Implantation.评估高密度脂蛋白胆固醇和 C 反应蛋白水平对经导管主动脉瓣置换术后 2 年死亡率的预测价值。
Am J Cardiol. 2020 Jul 1;126:66-72. doi: 10.1016/j.amjcard.2020.03.037. Epub 2020 Apr 8.
4
Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI.高敏 C 反应蛋白联合 logistic EuroSCORE 可改善行经导管主动脉瓣置换术患者的风险分层。
EuroIntervention. 2018 Aug 20;14(6):629-636. doi: 10.4244/EIJ-D-18-00059.
5
Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation.血清C反应蛋白水平对经导管主动脉瓣植入术后预测死亡率的影响。
Am J Cardiol. 2018 Jul 15;122(2):294-301. doi: 10.1016/j.amjcard.2018.04.005. Epub 2018 Apr 12.
6
2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.2016 年胸外科医师学会/美国心脏病学会经导管瓣膜治疗注册中心年度报告。
J Am Coll Cardiol. 2017 Mar 14;69(10):1215-1230. doi: 10.1016/j.jacc.2016.11.033. Epub 2016 Dec 9.
7
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.经导管主动脉瓣置换术后1年预后预测的风险评分和生物标志物。
Am Heart J. 2015 Oct;170(4):821-9. doi: 10.1016/j.ahj.2015.07.003. Epub 2015 Jul 10.
8
Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry.经导管主动脉瓣植入术后的死亡率结局及预测因素：巴西注册研究结果
Catheter Cardiovasc Interv. 2015 Apr;85(5):E153-62. doi: 10.1002/ccd.25778. Epub 2015 Jan 13.
9
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.C 反应蛋白升高与癌症的诊断、预后和病因。
Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831.
10
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.663 例重度主动脉瓣狭窄患者行经导管主动脉瓣植入术后早期和晚期死亡率的发生率和预测因素。
Circulation. 2011 Jan 25;123(3):299-308. doi: 10.1161/CIRCULATIONAHA.110.946533. Epub 2011 Jan 10.
Zotero 插件